CymitQuimica logo
Bcr-Abl

Bcr-Abl

Gli inibitori di Bcr-Abl sono terapie mirate che inibiscono la proteina di fusione Bcr-Abl, formata a seguito della traslocazione del cromosoma Philadelphia e responsabile della leucemia mieloide cronica (CML). Questa proteina influenza anche l'angiogenesi, contribuendo alla progressione tumorale. Gli inibitori di Bcr-Abl sono cruciali nel trattamento della CML e sono oggetto di ricerca per il loro potenziale nell'inibire l'angiogenesi in vari tipi di cancro. Presso CymitQuimica, offriamo inibitori di Bcr-Abl di alta qualità per supportare la tua ricerca in biologia del cancro, angiogenesi e terapie mirate.

Trovati 113 prodotti di "Bcr-Abl"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • BCR-ABL-IN-2

    CAS:
    BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I).
    Formula:C24H25Cl2N5O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:502.39
  • BCR-ABL-IN-7

    CAS:
    BCR-ABL-IN-7 is an inhibitor of ABL kinase activity in WT and T315I mutants.BCR-ABL-IN-7 can be used in chronic myeloid leukemia (CML) research.
    Formula:C19H16FN3O3S
    Purezza:98.28%
    Colore e forma:Solid
    Peso molecolare:385.41
  • CpCDPK1/TgCDPK1-IN-1

    CAS:
    CpCDPK1/TgCDPK1-IN-1 is a inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections.
    Formula:C18H17N5
    Purezza:99.61%
    Colore e forma:Solid
    Peso molecolare:303.36
  • PF-06651481-00

    CAS:
    <p>PF-06651481-00 (Bosutinib Isomer I) is a Bosutinib analog and a Bcr-Abl inhibitor.</p>
    Formula:C26H29Cl2N5O3
    Purezza:97.01%
    Colore e forma:Solid
    Peso molecolare:530.45
  • BCR-ABL-IN-1

    CAS:
    BCR-ABL-IN-1 is a BCR-ABL tyrosine kinase inhibitor (pIC50: 6.46) and may be used in the research of chronic myelogenous leukemia.
    Formula:C23H21F4N5O
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:459.44
  • Debio 0617B

    CAS:
    Debio 0617B inhibits kinases for AML stem cell treatment, targeting JAK, ABL, SRC, and STAT3-related tumours.
    Formula:C28H23ClF3N7O2
    Colore e forma:Solid
    Peso molecolare:581.98
  • Antiproliferative agent-30

    CAS:
    Antiproliferative agent-30 (Compound 8g) demonstrates broad-spectrum antiproliferative activity, with IC50 values of 0.054 nM, 0.008 nM, and 0.144 nM against
    Formula:C24H26N4O4
    Colore e forma:Solid
    Peso molecolare:434.49
  • c-ABL-IN-2

    CAS:
    C-ABL-IN-2 is a potent c-Abl protein inhibitor, promising for research in cancer and neurodegenerative diseases like ALS and PD.
    Formula:C21H20N4O
    Colore e forma:Solid
    Peso molecolare:344.41
  • PD-173956

    CAS:
    PD-173956 is an inhibitor of the Src family tyrosine kinases.
    Formula:C20H13Cl2FN4O
    Colore e forma:Solid
    Peso molecolare:415.25
  • BGB659

    CAS:
    BGB659 is effective inhibitor of RAF.
    Formula:C29H29F3N4O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:538.56
  • Tyrphostin AG 568

    CAS:
    Tyrphostin AG 568 promotes Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity. It also induces K562 to differentiate.
    Formula:C13H9N5O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:267.24
  • ON 146040

    CAS:
    ON 146040 is an effective inhibitor of PI3K isoforms with IC50s of 14 and 20 nM for PI3Kα and PI3Kδ, respectively.
    Formula:C24H23N7O3S
    Purezza:97.39%
    Colore e forma:Solid
    Peso molecolare:489.55
  • BCR-ABL-IN-6

    CAS:
    BCR-ABL-IN-6, an imatinib derivative, inhibits Bcr-AblWT (4.6 nM IC50) and T315I (277 nM), for chronic myeloid leukemia study.
    Formula:C27H22F3N5O2
    Colore e forma:Solid
    Peso molecolare:505.49
  • AN-019

    CAS:
    AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer.
    Formula:C25H17F6N5O
    Purezza:98.99%
    Colore e forma:Solid
    Peso molecolare:517.43
  • CHMFL-ABL-053

    CAS:
    CHMFL-ABL-053: potent, selective BCR-ABL/SRC/p38 inhibitor (IC50: 70/90/62 nM). Orally available, potential CML drug.
    Formula:C28H26F3N7O2
    Colore e forma:Solid
    Peso molecolare:549.55
  • AFG210

    CAS:
    AFG210 is a novel first-generation “type II” FLT3 inhibitor.
    Formula:C19H14F3N3O2
    Colore e forma:Solid
    Peso molecolare:373.33
  • PPY A

    CAS:
    PPY A is a potent inhibitor of T315l mutant and wild-type Abl kinase and inhibits the growth of Bcr-Abl T315l mutant or wild-type Bcr-Abl gene-transformed cells
    Formula:C22H20N4O2
    Purezza:98.77%
    Colore e forma:Solid
    Peso molecolare:372.42
  • SKLB 1028

    CAS:
    SKLB 1028, an oral EGFR/FLT3/Abl inhibitor, excels in AML and CML with Abl mutations.
    Formula:C24H29N9
    Purezza:99.99% - >99.99%
    Colore e forma:Solid
    Peso molecolare:443.55
  • CGP77675

    CAS:
    CGP77675 (ZINC1488120) is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates and
    Formula:C26H29N5O2
    Purezza:99.66%
    Colore e forma:Solid
    Peso molecolare:443.54
  • Nilotinib hydrochloride

    CAS:
    Nilotinib HCl (AMN-107 HCl), an oral Bcr-Abl inhibitor, targets neuroinflammation, cognitive issues, and chronic myelogenous leukemia.
    Formula:C28H23ClF3N7O
    Purezza:99.98%
    Colore e forma:Solid
    Peso molecolare:565.98